-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Akero Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
- Akero Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -32.5 %, a 24.5% decline year-over-year.
- Akero Therapeutics, Inc. annual Return On Equity for 2023 was -29.7 %, a 36% increase from 2022.
- Akero Therapeutics, Inc. annual Return On Equity for 2022 was -46.4 %, a 3.93% increase from 2021.
- Akero Therapeutics, Inc. annual Return On Equity for 2021 was -48.3 %, a 17% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)